Heterocyclic PDK1 inhibitors for use to treat cancer

• 收藏
• 分享

专利权人:

Inc.;Sunesis Pharmaceuticals

发明人:

Hansen, Stig K.,Binnerts, Minke E.

申请号：

AU2016342352

公开号：

AU2016342352A1

申请日:

2016.10.21

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Described are methods of use of compounds that inhibit PIF-mediated substrate binding by PDK1, which are useful as inhibitors of cancer growth or proliferation that is RSK2-dependent or AKT-independent. Also described are compositions of such compounds for use in such methods of treating cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/